CLAIM CARD
Mechanistically, the reduction in postprandial glucose variability observed in the Smedegaard 2026 trial is plausibly linked to the effects of whey protein on gastric emptying, insulinotropic amino acid release, and subsequent insulin secretion. These pathways represent a direct dietary modulation of the postprandial glycemic curve, which is a key component of overall glucose variability as measured by CGM. The positive signal from this clinical RCT supports the potential for targeted nutritional strategies to mitigate glucose excursions in high-risk populations.
Evidence grade: exploratory
Contradiction status: none
Publication: becb4785-6244-41cd-ba08-c47e58dca346
Provenance: Derivation Web chain
Citation Support
source_1Sidki 2026source_2Gravesteijn 2023source_3Lu 2021source_4Lee 2020source_5Franceschi 2026